Romidepsin for peripheral T-cell lymphoma

Grants

Funding Acknowledgements

HM Prince has received honoraria, consultancies and research support from Celgene Pty Ltd. M Dickinson has received research support from Celgene Pty Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.